Moore Capital Management’s Sight Sciences SGHT Stock Holding History

Moore Capital Management’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-23,653	Closed	-$537K	–	847
2021 Q3	$537K	Buy	+23,653	New	+$778K	0.01%	540

Other funds holding SGHT

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Moore Capital Management's SGHT Position: Q4 2021 in Review

Moore Capital Management sold out of Sight Sciences (SGHT) in Q4 2021, closing a stake of 23,653 shares — an estimated $537K sold.

Moore Capital Management first reported a position in SGHT in Q3 2021 and held it in 1 quarter. The position peaked at $537K in Q3 2021. 60 funds tracked by Wall St. Rank hold SGHT as of Q4 2021.

Moore Capital Management reported no remaining Sight Sciences position as of Q4 2021 after selling out during the quarter.
Moore Capital Management sold 23,653 Sight Sciences shares in Q4 2021, an estimated $537K.
Moore Capital Management first reported a position in Sight Sciences in Q3 2021 and held it in 1 quarter.
Moore Capital Management's Sight Sciences position peaked at $537K in Q3 2021.
60 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2021.

Based on Moore Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.